Raymond James Financial Inc. Boosts Stock Holdings in Xylem Inc. $XYL

Key Points

• Raymond James Financial Inc. increased its stake in Xylem Inc. by 7.9% in the first quarter, now owning 376,253 shares valued at approximately $44.9 million.
• Xylem reported earnings of $1.26 per share, surpassing the consensus estimate of $1.15, with a 6.1% year-over-year revenue growth reaching $2.30 billion.
• The company has declared a quarterly dividend of $0.40 per share, with a dividend yield of 1.1% and an anticipated payout ratio of 41.56%.

Raymond James Financial Inc. increased its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 7.9% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 376,253 shares of the industrial products company's stock after buying an additional 27,657 shares during the quarter. Raymond James Financial Inc. owned about 0.15% of Xylem worth $44,947,000 as of its most recent SEC filing.

A number of other large investors have also recently made changes to their positions in XYL. Northern Trust Corp grew its holdings in shares of Xylem by 42.0% during the fourth quarter. Northern Trust Corp now owns 3,268,433 shares of the industrial products company's stock valued at $379,204,000 after buying an additional 966,399 shares during the last quarter. Nuveen LLC purchased a new stake in shares of Xylem during the first quarter valued at $99,726,000. OVERSEA CHINESE BANKING Corp Ltd grew its holdings in shares of Xylem by 390.5% during the first quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 1,021,337 shares of the industrial products company's stock valued at $122,009,000 after buying an additional 813,100 shares during the last quarter. Vaughan Nelson Investment Management L.P. purchased a new stake in shares of Xylem during the first quarter valued at $89,828,000. Finally, Universal Beteiligungs und Servicegesellschaft mbH purchased a new stake in shares of Xylem during the fourth quarter valued at $83,139,000. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Price Performance

Shares of XYL stock traded down $0.9850 during mid-day trading on Monday, hitting $142.7550. 897,193 shares of the stock were exchanged, compared to its average volume of 1,463,502. The firm has a fifty day moving average of $134.27 and a 200 day moving average of $126.39. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $145.33. The company has a market cap of $34.75 billion, a PE ratio of 37.08, a price-to-earnings-growth ratio of 2.49 and a beta of 1.11.

Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same period in the prior year, the company posted $1.09 EPS. The company's revenue for the quarter was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Thursday, August 28th. Xylem's dividend payout ratio is presently 41.56%.

Analysts Set New Price Targets

Several equities research analysts have commented on XYL shares. Raymond James Financial raised shares of Xylem to a "hold" rating in a report on Thursday, May 15th. Robert W. Baird decreased their price objective on Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a report on Wednesday, April 30th. Royal Bank Of Canada boosted their price objective on Xylem from $143.00 to $147.00 and gave the company an "outperform" rating in a report on Wednesday, April 30th. UBS Group boosted their price objective on Xylem from $164.00 to $168.00 and gave the company a "buy" rating in a report on Tuesday, August 5th. Finally, Wall Street Zen raised Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Six investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $151.57.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.